Search research articles
Contact Us
Filters
Showing results (201-210 of 237) with videos related to
Page
of 24
Sort By:
Nature Chemistry
|
September 25, 2019
Fungal indole alkaloid biogenesis through evolution of a bifunctional reductase/Diels-Alderase
Qingyun Dan, Sean A Newmister, Kimberly R Klas, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
The Journal of Experimental Medicine
|
July 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
Marie Ménard, Hiroyuki Yoda, Nicole Nasholm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold, Maneesh Pingle, Steven J Brickner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial
Alison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Journal of Radioanalytical and Nuclear Chemistry
|
August 25, 2015
Certification of Total Arsenic in Blood and Urine Standard Reference Materials by Radiochemical Neutron Activation Analysis and Inductively Coupled Plasma - Mass Spectrometry
Rick L Paul, W Clay Davis, Lee Yu, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Science (New York, N.Y.)
|
January 8, 2021
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction
Scott B Biering, David L Akey, Marcus P Wong, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)
Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 237) with videos related to
Sort By:
Page
of 24
Nature Chemistry
|
September 25, 2019
Fungal indole alkaloid biogenesis through evolution of a bifunctional reductase/Diels-Alderase
Qingyun Dan, Sean A Newmister, Kimberly R Klas, et al.
Cell Reports
|
March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
Miller Huang, Wanqi Fang, Alvin Farrel, et al.
The Journal of Experimental Medicine
|
July 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma
Marie Ménard, Hiroyuki Yoda, Nicole Nasholm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2012
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold, Maneesh Pingle, Steven J Brickner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial
Alison M Schram, Abdul Rafeh Naqash, Eric B Haura, et al.
Journal of Radioanalytical and Nuclear Chemistry
|
August 25, 2015
Certification of Total Arsenic in Blood and Urine Standard Reference Materials by Radiochemical Neutron Activation Analysis and Inductively Coupled Plasma - Mass Spectrometry
Rick L Paul, W Clay Davis, Lee Yu, et al.
Cell Reports
|
December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma
Christopher S Hackett, David A Quigley, Robyn A Wong, et al.
Science (New York, N.Y.)
|
January 8, 2021
Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction
Scott B Biering, David L Akey, Marcus P Wong, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)
Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Page
of 24